![Probing Membrane Association of α-Synuclein Domains with VDAC Nanopore Reveals Unexpected Binding Pattern | Scientific Reports Probing Membrane Association of α-Synuclein Domains with VDAC Nanopore Reveals Unexpected Binding Pattern | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-40979-8/MediaObjects/41598_2019_40979_Fig1_HTML.png)
Probing Membrane Association of α-Synuclein Domains with VDAC Nanopore Reveals Unexpected Binding Pattern | Scientific Reports
![Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson's disease | Molecular Brain | Full Text Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson's disease | Molecular Brain | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13041-020-00648-8/MediaObjects/13041_2020_648_Fig1_HTML.png)
Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson's disease | Molecular Brain | Full Text
![Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons | Cell Death & Disease Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-019-2091-2/MediaObjects/41419_2019_2091_Fig1_HTML.png)
Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons | Cell Death & Disease
![Transmission of α-synuclein seeds in neurodegenerative disease: recent developments | Laboratory Investigation Transmission of α-synuclein seeds in neurodegenerative disease: recent developments | Laboratory Investigation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41374-019-0195-z/MediaObjects/41374_2019_195_Fig1_HTML.png)
Transmission of α-synuclein seeds in neurodegenerative disease: recent developments | Laboratory Investigation
![IJMS | Free Full-Text | Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease | HTML IJMS | Free Full-Text | Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease | HTML](https://www.mdpi.com/ijms/ijms-22-06517/article_deploy/html/images/ijms-22-06517-g001.png)
IJMS | Free Full-Text | Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease | HTML
![Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing | Scientific Reports Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-68808-3/MediaObjects/41598_2020_68808_Fig1_HTML.jpg)
Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing | Scientific Reports
![PDF) The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease PDF) The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease](https://i1.rgstatic.net/publication/328671780_The_small_molecule_alpha-synuclein_misfolding_inhibitor_NPT200-11_produces_multiple_benefits_in_an_animal_model_of_Parkinson's_disease/links/5bdb37004585150b2b97375f/largepreview.png)
PDF) The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease
![The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson's disease - ScienceDirect The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0301462220302428-ga1.jpg)
The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson's disease - ScienceDirect
![Characterization of SNpc intraneuronal α-Synuclein accumulations. (a)... | Download Scientific Diagram Characterization of SNpc intraneuronal α-Synuclein accumulations. (a)... | Download Scientific Diagram](https://www.researchgate.net/publication/321342798/figure/fig2/AS:566064615313409@1511971729998/Characterization-of-SNpc-intraneuronal-a-Synuclein-accumulations-a-Double-labeling_Q640.jpg)
Characterization of SNpc intraneuronal α-Synuclein accumulations. (a)... | Download Scientific Diagram
![Animal models of α-synucleinopathy for Parkinson disease drug development | Nature Reviews Neuroscience Animal models of α-synucleinopathy for Parkinson disease drug development | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrn.2017.75/MediaObjects/41583_2017_Article_BFnrn201775_Fig1_HTML.jpg)
Animal models of α-synucleinopathy for Parkinson disease drug development | Nature Reviews Neuroscience
![α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease | Nature Communications α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-04422-2/MediaObjects/41467_2018_4422_Fig1_HTML.jpg)
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease | Nature Communications
![Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease | Acta Neuropathologica Communications | Full Text Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease | Acta Neuropathologica Communications | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40478-019-0814-3/MediaObjects/40478_2019_814_Fig4_HTML.png)
Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease | Acta Neuropathologica Communications | Full Text
![CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects | Scientific Reports CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-76927-0/MediaObjects/41598_2020_76927_Fig1_HTML.png)
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects | Scientific Reports
![Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis | Nature Neuroscience Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis | Nature Neuroscience](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41593-019-0457-5/MediaObjects/41593_2019_457_Fig1_HTML.png)
Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis | Nature Neuroscience
![Detection of α -synuclein oligomers in synucleinopathy brains using... | Download Scientific Diagram Detection of α -synuclein oligomers in synucleinopathy brains using... | Download Scientific Diagram](https://www.researchgate.net/profile/Julia-Gerson/publication/270650947/figure/fig2/AS:295061184106499@1447359476627/Detection-of-a-synuclein-oligomers-in-synucleinopathy-brains-using-oligomer-speci-fi-c.png)
Detection of α -synuclein oligomers in synucleinopathy brains using... | Download Scientific Diagram
![Biomolecules | Free Full-Text | Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein | HTML Biomolecules | Free Full-Text | Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein | HTML](https://www.mdpi.com/biomolecules/biomolecules-05-00282/article_deploy/html/images/biomolecules-05-00282-g003.png)
Biomolecules | Free Full-Text | Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein | HTML
Single-Channel Electrophysiology Reveals a Distinct and Uniform Pore Complex Formed by α-Synuclein Oligomers in Lipid Membranes
![α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro](https://www.eneuro.org/content/8/1/ENEURO.0330-20.2020/F1.large.jpg)
α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro
![Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies - Villar‐Piqué - 2016 - Journal of Neurochemistry - Wiley Online Library Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies - Villar‐Piqué - 2016 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/40c03e88-599c-4477-b2a0-b02fc5f49145/jnc13249-fig-0002-m.jpg)